IMPEL NEUROPHARMA INC (IMPL) News

IMPEL NEUROPHARMA INC (IMPL): $0.04

0.02 (-27.27%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add IMPL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#221 of 359

in industry

Filter IMPL News Items

IMPL News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest IMPL News From Around the Web

Below are the latest news stories about IMPEL PHARMACEUTICALS INC that investors may wish to consider to help them evaluate IMPL as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start the week with a breakdown of the biggest pre-market stock movers that are worth watching on Monday morning!

William White on InvestorPlace | November 27, 2023

Billionaire Marc Lasry’s Top 10 Stock Picks

In this piece, we will take a look at billionaire Marc Lasry’s top ten stock picks. If you want to skip our introduction to the billionaire hedge fund boss and the general investing climate, then take a look at Billionaire Marc Lasry’s Top 5 Stock Picks. Marc Lasry is a hedge fund billionaire who started […]

Yahoo | October 30, 2023

Impel Pharmaceuticals Announces Exploration of Strategic Alternatives

SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ: IMPL) (“Impel” or “the Company”), a commercial-stage biopharmaceutical company with a mission to develop transformative therapies for people suffering from diseases with high unmet medical needs, today announced that it has initiated an exploration of strategic alternatives. As part of this process, the Company plans to consider a wide range of options with a focus on maximizing shareholder value, including a potentia

Yahoo | October 5, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!

William White on InvestorPlace | September 13, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting off the workweek right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!

William White on InvestorPlace | September 11, 2023

Why Is AGBA Group (AGBA) Stock Up 32% Today?

AGBA Group (AGBA) stock is climbing higher on Friday after the company announced a $50 million equity purchase agreement.

William White on InvestorPlace | September 8, 2023

Why Is Grom Social Enterprises (GROM) Stock Down 53% Today?

Grom Social Enterprises (GROM) stock is taking a beating on Friday after the company went through a reverse stock split yesterday.

William White on InvestorPlace | September 8, 2023

Why Is Impel Pharmaceuticals (IMPL) Stock Up 32% Today?

Impel Pharmaceuticals (IMPL) stock is on the rise Friday after the company announced an amended agreement with Oaktree Fund Administration.

William White on InvestorPlace | September 8, 2023

Why Is Rosecliff Acquisition (RCLF) Stock Down 17% Today?

Rosecliff Acquisition (RCLF) stock is falling on Friday after the company provided investors with an update to its merger with Spectral MD.

William White on InvestorPlace | September 8, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Pre-market stock movers are a hot topic worth checking out on Friday with a look at the biggest winners and losers today!

William White on InvestorPlace | September 8, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!